Patients with NF1 carry a higher risk for the development of other RAS pathway-associated tumors (e.g. plexiform neurofibromas) and glial tumors, including brainstem gliomas and diffuse astrocytomas (6, 7). The gene discussed is NF1; the disease is plexiform neurofibroma.